Nuvaira has filed a notice of an exempt offering of securities to raise $63,576,279.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Nuvaira is raising up to $63,576,279.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Nuvaira
Nuvaira, Inc. develops innovative and groundbreaking therapies that aim to improve the lives of the more than 65 million people around the world with obstructive lung disease. Founded in 2008, Nuvaira was established to address clinical needs in the treatment of overactive airway nerves, a common disease feature of both COPD and asthma. Nuvaira is a privately held medical device company, headquartered in Minneapolis, Minnesota USA and has more than 75 patents issued and pending worldwide. The dNerva Lung Denervation System is CE Mark approved. The dNerva lung denervation system is under clinical investigation and is not commercially available in the USA.
To learn more about Nuvaira, visit https://nuvaira.com/
Nuvaira Linkedin Page: https://www.linkedin.com/company/nuvaira-inc./
Contact:
Dennis Wahr, Chief Executive Officer
763-450-2800
https://www.linkedin.com/in/dennis-wahr-m-d-8b3279a7/
SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.
